Join
Perrigo Company plc logo

PRGO

NYSE

Perrigo Company plc

SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations
News25/Ratings11

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, and Dr. Fresh. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations in the United States, as well as pharmaceutical and diagnostic products in Israel. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Price$10.84-0.85 (-7.31%)
2026-03-042026-06-05
News · 26 weeks62-94%
2025-12-14: 22025-12-21: 02025-12-28: 02026-01-04: 02026-01-11: 02026-01-18: 02026-01-25: 02026-02-01: 12026-02-08: 22026-02-15: 22026-02-22: 32026-03-01: 12026-03-08: 42026-03-15: 42026-03-22: 22026-03-29: 42026-04-05: 12026-04-12: 02026-04-19: 22026-04-26: 32026-05-03: 122026-05-10: 172026-05-17: 02026-05-24: 22026-05-31: 02026-06-07: 0
2025-12-142026-06-07
Mix5190d
  • Insider26(51%)
  • SEC Filings16(31%)
  • Other6(12%)
  • Earnings2(4%)
  • Dividends1(2%)

Latest news

25 items

PRGO FAQ

6 questions
  • What does Perrigo Company plc do?
    Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and...
  • Where does PRGO stock trade?
    Perrigo Company plc (PRGO) is listed on NYSE.
  • What sector and industry is PRGO in?
    Perrigo Company plc operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • What are analysts saying about PRGO?
    Perrigo Company plc has had 8 recent analyst actions on file. The most recent action was from Analyst: Neutral with a $2000.00 price target on 2025-11-06. Recent price targets range from $2000.00 to $4900.00.
  • What companies are similar to PRGO?
    Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare PRGO side-by-side with any of them on Quantisnow.
  • How can I track PRGO on Quantisnow?
    Quantisnow aggregates Perrigo Company plc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PRGO to receive live email and push alerts on every new disclosure.